New developments for anti-HIV treatment (2015)
- Autores:
- Autor USP: CASSEB, JORGE SIMÃO DO ROSÁRIO - IMT
- Unidade: IMT
- Assuntos: HIV; TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título: Frontiers in clinical drug research : HIV
- Volume/Número/Paginação/Ano: 289 p.
-
ABNT
ARRUDA, Liã Bárbara e CASSEB, Jorge Simão do Rosário. New developments for anti-HIV treatment. Frontiers in clinical drug research : HIV. Tradução . Sharjah: Bentham, 2015. p. 289 . . Acesso em: 14 jul. 2025. -
APA
Arruda, L. B., & Casseb, J. S. do R. (2015). New developments for anti-HIV treatment. In Frontiers in clinical drug research : HIV (p. 289 ). Sharjah: Bentham. -
NLM
Arruda LB, Casseb JS do R. New developments for anti-HIV treatment. In: Frontiers in clinical drug research : HIV. Sharjah: Bentham; 2015. p. 289 .[citado 2025 jul. 14 ] -
Vancouver
Arruda LB, Casseb JS do R. New developments for anti-HIV treatment. In: Frontiers in clinical drug research : HIV. Sharjah: Bentham; 2015. p. 289 .[citado 2025 jul. 14 ] - Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring
- Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status
- Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients
- Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial
- Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas
- Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection
- Dichotomy in Fatal Outcomes in a Large Cohort of People Living with HTLV-1 in Sao Paulo, Brazil
- IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1
- Infectologia ambulatorial: diagnóstico e tratamento
- Infecção pelo HTLV-I e HTVL-II
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
